MBC Bio Labs
October Newsletter

AI Antibody Drug Discovery – the BigHat story with founders Mark DePristo and Peyton Greenside
Please join us for a chat with CEO Mark DePristo, and CSO Peyton Greenside of BigHat BioSciences. Mark is a leader in applying computational and statistical techniques to biomedical challenges in genomics and biochemistry. And Peyton, a pioneer of deep learning applied to life science problems, she has developed computational, statistical, and AI/ML techniques to model, understand, and optimize biological sequences in academia and industry.
Click to Learn More
MBC BioLabs & PerkinElmer Partnership: Launch Event

PerkinElmer invites you to celebrate their new partnership with MBC Biolabs! Please join us to enjoy socially distanced food, beverages and live music. Come discuss world class science, innovation, entrepreneurship, and meet residents working to move early-stage science from the lab bench to clinical trials. Attendees will receive fun giveaways and be entered to win cool prizes.

PerkinElmer's partnership helps provide state-of-the-art equipment and a vibrant community that enables and empowers entrepreneurial scientists to run experiments on day one.

October 28th, 12-6PM @ MBC biolabs, 930 Brittan Ave, San Carlos, CA
Click to RSVP
Golden Ticket

AbbVie & MBC BioLabs Invite You to Apply for the 2021 AbbVie Golden Ticket!

AbbVie Golden Tickets will be awarded to two early-stage companies developing novel, transformational therapies for autoimmune, oncology, neuroscience, eye care or aesthetics.

Winners will receive:

  • One year of free lab space and access to shared amenities and services provided by MBC BioLabs in San Francisco or San Carlos.
  • Opportunities to engage with AbbVie scientific and business leaders.

To apply, send your non-confidential company presentation to GoldenTicket@abbvie.com. Semi-finalists will be invited for virtual presentation on December 2nd.

Application Deadline:
October 19, 2021
Click to Apply
Eisai Innovation and MBC BioLabs Announce 2021 Eisai Golden Ticket Competition to Accelerate Early Drug Discovery and Research Efforts
Eisai Innovation, Inc. (EII), an affiliate of Eisai Co., Ltd. the fully integrated pharmaceutical company based in Tokyo, Japan, is partnering with MBC BioLabs to award one Golden Ticket to an innovative life science startup. Eisai is interested in drug discovery technologies, novel targets and biology that can be utilized in oncology and neurology.
Click to Apply
2021 Astellas Future Innovator Prize at MBC BioLabs
Astellas is pleased to announce that the application portal is now open for the Astellas Future Innovator Prize. We are proud to offer this 'golden ticket' for one year of free lab space and access to the shared amenities and services provided at MBC BioLabs, a top-tier incubator and lab facility in the Bay Area to the winner among entrepreneurial scientists, emerging life sciences companies and biotechnology start-ups.
Click to Sign Up
In The News

Weatherwax Biotechnologies is the Winner of the MBC BioLabs Servier Spark Awards
We are excited to announce that Weatherwax Biotechnologies is the winner of the MBC BioLabs Servier Spark Awards, an initiative offering entrepreneurial innovators lab space with MBC BioLabs and continued mentorship from Servier. Congratulations to the teams! Check out more about Servier's partnership strategy...
Click to Read More
New Companies

TRIO Pharmaceuticals, Inc. Is a Cancer Immunotherapeutics Company Pioneering Dual Action Drugs to Generate Immunogenic Tumors
TRIO's innovative antibody drugs directly stop tumor growth and selectively stop immunosuppression in the tumor without targeting the current immune checkpoint pathways. TRIO is developing a proprietary platform of dual action tumor immunity-enhancing drugs aimed at treating cancers of high unmet medical needs by targeting specific antigens on the cancer cells and immunosuppressor cells in the tumor microenvironment. TRIO has an experienced team that has developed FDA-approved drugs.
MBC BioLabs, Enabling Awesome
bottom border